East Rutherford, NJ – March 11, 2015 – Cambrex Corporation (NYSE: CBM, “Cambrex”) is pleased to announce that it has been recognized as a 2015 CMO Leadership Award recipient for exemplary efforts in the area of Regulatory Compliance. This award will be presented in Life Science Leader magazine’s March 2015 CMO Leadership Awards issue.
Now in its fourth year, the CMO Leadership Awards were developed by Life Science Leader based on industry research conducted by Nice Insight. The awards incorporate the common filters used by pharmaceutical executives when selecting CMOs with the added filter of peer feedback. Unlike other industry awards, the only recommendations that count towards the CMO Leadership Awards are those from the pharmaceutical and biopharmaceutical companies using contract manufacturing services.
Cambrex was chosen because it was rated in the top 10% of companies within the Regulatory category. Cambrex will be accepting the award at the Annual Leadership Awards dinner on March 18, 2015 at the W Hotel in New York City.
Steven Klosk, President and CEO of Cambrex commented, “I am extremely proud that Cambrex has been selected as a winner of the 2015 CMO Leadership award in Regulatory Compliance. Cambrex puts a strong focus on maintaining operational excellence at all of our sites worldwide. Receiving this award demonstrates our continued commitment to our customers to operate with outstanding quality systems and maintain a strong regulatory record.”